









Markets
/
Stocks
/
nasdaq-tndm
/

Tandem Diabetes Care Inc

TNDM

11.790USD

-0.210-1.75%

Close 09/29, 16:00（ET）Quotes delayed by 15 min

796.19MMarket Cap

LossP/E TTM



Tandem Diabetes Care Inc

11.790

-0.210-1.75%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Tandem Diabetes Care Inc

Currency: USD Updated: 2025-09-29

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tandem Diabetes Care Inc's Score

Industry at a Glance

Industry Ranking

89 / 207

Overall Ranking

210 / 4714

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 23 analysts

Hold

Current Rating

21.286

Target Price

+77.38%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Tandem Diabetes Care Inc Highlights

StrengthsRisks

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 17.35% year-on-year.

Overvalued

The company’s latest PE is -3.83, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 76.82M shares, decreasing 12.20% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 19.68K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.67.

Financial Health

Currency: USD Updated: 2025-09-29

The company's current financial score is 7.10, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 240.68M, representing a year-over-year increase of 8.46%, while its net profit experienced a year-over-year increase of 70.05%.

Score

Industry at a Glance

Previous score

7.10

Change



Financials

4.54

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.71

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.03

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.23

Key Metrics

Free cash flow

No Data

Tandem Diabetes Care Inc's Company Valuation

Currency: USD Updated: 2025-09-29

The company’s current valuation score is 7.08, which is lower than the Healthcare Equipment & Supplies industry's average of 7.17. Its current P/E ratio is -3.83, which is -14.21% below the recent high of -3.28 and -1286.97% above the recent low of -53.08.

Score

Industry at a Glance

Previous score

7.08

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 89/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-29

The company’s current earnings forecast score is 6.87, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Tandem Diabetes Care Inc is 16.00, with a high of 51.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

6.87

Change

Support & Resistance

No Data

Analyst Rating

Based on 23 analysts

Hold

Current Rating

21.286

Target Price

+77.38%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Tandem Diabetes Care Inc

TNDM

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-29

The company’s current price momentum score is 5.50, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 12.98 and the support level at 11.14, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.13

Change

0.37

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.023

Sell

RSI(14)

42.296

Neutral

STOCH(KDJ)(9,3,3)

13.084

Sell

ATR(14)

0.702

High Vlolatility

CCI(14)

-132.798

Sell

Williams %R

93.772

Oversold

TRIX(12,20)

0.027

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

12.232

Sell

MA10

12.464

Sell

MA20

12.466

Sell

MA50

12.915

Sell

MA100

16.360

Sell

MA200

21.820

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 113.72%, representing a quarter-over-quarter increase of 0.44%. The largest institutional shareholder is The Vanguard, holding a total of 7.36M shares, representing 10.89% of shares outstanding, with 3.72% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

9.76M

-3.17%

The Vanguard Group, Inc.

Star Investors

7.28M

-1.99%

Sessa Capital

4.47M

GW&K Investment Management, LLC

2.86M

+34.87%

ArrowMark Colorado Holdings, LLC

2.72M

-0.27%

State Street Global Advisors (US)

2.69M

-2.80%

Hood River Capital Management LLC

2.31M

+80.90%

Two Sigma Investments, LP

1.32M

-24.21%

Paradice Investment Management LLC

1.65M

+72.51%

Stephens Investment Management Group, LLC

1.71M

+9.71%

Risk Assessment

Currency: USD Updated: 2025-09-29

The company’s current risk assessment score is 4.01, which is lower than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 1.49. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.